Oct. 10, 2024 — The risk of asthma in the child can be reduced by nearly half if the mother engages in active physical exercise at least three times a week during pregnancy, compared to a child ...

Difficulty breathing—whether it's wheezing, chest pain or tightness, shortness of breath, or coughing—is characteristic of asthma. But it can also occur with gastrointestinal reflux disease (GERD), ...

If you have asthma, running might worsen your symptoms, but there are precautions you can take to make it safer. Typically, symptoms like wheezing, coughing, and shortness of breath begin about 15 ...

Because of this, it's easy to assume that all types of asthma are fundamentally the same. While that's true to an extent, differences between the types matter—making an accurate diagnosis crucial. You ...

Their analysis shows that children's risk of developing asthma later in life can be more reliably predicted by observing the dynamic development of symptoms during the first year of life.

CMS is expected to announce in early 2025 the list of up to 15 Medicare Part D drugs that will be subject to price negotiations in 2025, with negotiated prices expected to be implemented in 2027.

Nearly 28 million people in the U.S. have asthma, or about one in 12 people — and depending on where you live, the condition may be more difficult to manage. The Asthma and Allergy Foundation of ...

People with asthma or severe acne will no longer be banned from joining Britain’s armed forces, Defence Secretary John Healey has said. Healey said he wanted to scrap "outdated policies" that ...

GSK’s new asthma drug Relvar Ellipta has shown itself ... Developed with US respiratory specialist firm Innoviva, the drug (known as Breo Ellipta in the US) is GSK’s follow up to its ...

Sub-optimally controlled asthma is common, in part because of normalisation of symptoms, underuse of preventer therapy, overuse of reliever therapy, and poor inhaler technique. Ensuring patients are ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Philip Morris International has agreed to sell its Vectura asthma inhaler maker for only a third of what it ...